LASERTERAPIA DE BAIXA INTENSIDADE COMO ADJUVANTE NA CICATRIZAÇÃO DE FERIDAS EM PESSOAS COM DOENÇA DO PÉ DIABÉTICO: REVISÃO INTEGRATIVA DA LITERATURA.

This study aimed to identify, in the scientific literature, the benefits of low-level laser therapy (LLLT) as an adjuvant in the wound healing process of individuals with Diabetes Mellitus (DM). An integrative review was conducted following the PRISMA 2020 guidelines, analyzing publications from 2016 to 2025 in PubMed, SciELO, BVS, and Google Scholar databases. Five studies met the inclusion criteria. The results demonstrated that LLLT, applied with wavelengths between 630 and 660 nm and energy densities ranging from 3 to 8 J/cm², promoted accelerated epithelialization, increased granulation tissue formation, improved tissue perfusion, and reduced pain and inflammation. The studies predominantly included male participants aged between 56 and 64 years, who are more susceptible to diabetic foot complications. Findings indicate that LLLT is a safe, accessible, and effective technology with potential to prevent amputations and optimize clinical outcomes. However, standardized clinical protocols and larger randomized trials are still required to strengthen scientific evidence.